Keros Therapeutics, Inc. · NASDAQ:KROS

Madison Avenue Partners, LP's stake in Keros Therapeutics, Inc. fell to 2.70% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Madison Avenue Partners, LP's stake in Keros Therapeutics, Inc. fell to 2.70%, 823,707 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
2.70%
Shares
823,707
Intent
Passive
What changed
Fell below 5%
Filed together
6 holders

The filing in full

HolderStakeShares
Madison Avenue International LP2.70%823,707
Madison Avenue Partners, LP2.70%823,707
EMAI Management, LLC2.70%823,707
Madison Avenue GP, LLC2.70%823,707
Caraway Jackson Investments LLC2.70%823,707
Eli Samaha2.70%823,707

Source

View original at SEC

Related